cropped-logo.png

RegenSight

We are the TECH Company

  • Company
      • About Us
      • Team
      • Resources & Opportunities
  • Science & Technology
      • Technologies
      • Projects
      • Clinical Trials
      • Visual Disorder
      • Publications and Presentations
  • Products
      • Devices for the CXL
        • C4V CHROMO4VIS
        • RitSight
        • DoRSight
      • Medical Professionals
      • Partnership
  • Granting & Investing
      • Public Granting
      • Investing
  • News & Media
  • Contacts
  • English
    • Italiano

Home

Monthly Archives: June 2023

Screenshot 2023-06-01 084144
June 1, 2023
by Marco Lombardo News

Pre-clinical validation outcomes of theranostic-guided corneal cross-linking published

In a recent study published in the prestigious Journal of Cataract & Refractive Surgery, theranostic-guided corneal cross-linking has been confirmed to induce precise and predictive corneal tissue strengthening in eye-bank human donor tissues through  ...

Leggi di più

Search

Recent Posts

  • A Thousand Steps Toward a Clearer World with Theranostics
  • C4V CHROMO4VIS receives CE Certification under MDR: A historic milestone for Precision Medicine in Ophthalmology
  • Regensight is sponsor of the World Keratoconus Congress 2025
  • RitSight has been issued the MDR CE Certification
  • The Teracor project for the correction of visual disorders with theranostics is moving forward quickly

Recent Comments

    Archives

    • August 2025
    • May 2025
    • March 2025
    • January 2025
    • September 2024
    • July 2024
    • June 2024
    • April 2024
    • February 2024
    • November 2023
    • September 2023
    • August 2023
    • June 2023
    • May 2023
    • April 2023
    • January 2023
    • December 2022
    • October 2022
    • September 2022
    • August 2022
    • June 2022
    • January 2022
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021

    Categories

    • BUSINESS
    • News
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Research Award

    Mario Lombardo

    To a young researcher committed to the study of keratoconus

    Apply
    cropped-logo.png

    The TECH Company

    Regensight develops and markets theranostic ophthalmic medical devices to improve vision and quality of life.

    Info
    Regensight srl is certified under UNI CEI EN ISO 13485:2021. Notified Body: TÜV Rheinland Italia.

    Information notice pursuant to Article 13 of EU Regulation 2016/679.

    Links
    • Home
    • Products
    • Contacts
    • News & Media
    • Privacy Policy
    • Cookies Policy
    Notes

    The information on this website is solely for healthcare professionals and is not promotional. By continuing, the user confirms they are a medical professional.

    Sign Up

    Keep me up to date with content, updates, and offers from Phlox

    "MailChimp" Plugin is Not Activated! In order to use this element, you need to install and activate this plugin.
    © 2025. Regensight | Creative web design by Arkomedia Web Agency
    Shopping Basket